Skip to Main Content

As interest grows in toughening the Sunshine Act in the U.S., a new analysis finds requirements for reporting financial relationships between drug makers and doctors in nine European countries are inconsistent and often inadequate, and the data is also sometimes hard to access.

For instance, only three countries — France, Portugal, and Latvia — have laws requiring companies to report financial ties. Five others follow a self-policing system established by an industry trade group, which means these countries allow physicians to choose whether disclosure reports are filed. And countries that adhere to the industry approach exclude food and drinks from being reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED